Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Agile Therapeutics Inc. diskutieren

Agile Therapeutics Inc.

WKN: A3D7A3 / Symbol: AGRX / Name: Agile Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,21 €
-

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 11,19
Veränderung
Endet am 07.06.24

Agile Therapeutics, Inc. (NASDAQ: AGRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for AGRX provided by MarketBeat

Agile Therapeutics, Inc. (NASDAQ: AGRX) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for AGRX provided by MarketBeat

Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AGRX provided by MarketBeat

Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AGRX provided by MarketBeat